Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies

NCT00473551 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Terminated due to slow accrual.

Conditions

Leukemia
Lymphoma
Myeloma

Interventions

DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Mesna
RADIATION: Radiation Treatment
PROCEDURE: Stem Cell Transplantation (SCT)
DRUG: Sirolimus
PROCEDURE: Anti-third Party Cytolytic T-lymphocytes (CTL)

Sponsor

M.D. Anderson Cancer Center